Cite
Patel JN, Jiang C, Owzar K, et al. Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenet Genomics. 2021;31(9):215-220doi: 10.1097/FPC.0000000000000442.
Patel, J. N., Jiang, C., Owzar, K., Mulkey, F., Luzum, J. A., Mamon, H. J., Haller, D. G., Dragovich, T., Alberts, S. R., Bjarnason, G., Willet, C. G., Niedzwiecki, D., Enzinger, P., Ratain, M. J., Fuchs, C., & McLeod, H. L. (2021). Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenetics and genomics, 31(9), 215-220. https://doi.org/10.1097/FPC.0000000000000442
Patel, Jai N, et al. "Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)." Pharmacogenetics and genomics vol. 31,9 (2021): 215-220. doi: https://doi.org/10.1097/FPC.0000000000000442
Patel JN, Jiang C, Owzar K, Mulkey F, Luzum JA, Mamon HJ, Haller DG, Dragovich T, Alberts SR, Bjarnason G, Willet CG, Niedzwiecki D, Enzinger P, Ratain MJ, Fuchs C, McLeod HL. Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenet Genomics. 2021 Dec 01;31(9):215-220. doi: 10.1097/FPC.0000000000000442. PMID: 34149004; PMCID: PMC8490297.
Copy
Download .nbib